COMMISSION IMPLEMENTING REGULATION (EU) 2015/1201
of 22 July 2015
renewing the approval of the active substance fenhexamid in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
(Text with EEA relevance)
Article 1
Renewal of the approval of active substance
Article 2
Amendments to Implementing Regulation (EU) No 540/2011
Article 3
Entry into force and date of application
ANNEX I
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
||||||||||||
Fenhexamid CAS No: 126833-17-8 CIPAC No: 603 |
N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexane-1-carboxamide |
≥ 975 g/kg The following relevant impurity must not exceed a certain threshold in the technical material:
|
1 January 2016 |
31 December 2030 |
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on fenhexamid, and in particular Appendices I and II thereof, shall be taken into account. In this overall assessment Member States shall pay particular attention to:
Conditions of use shall include risk mitigation measures, where appropriate. |
ANNEX II
|
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
||||||||||||
‘85 |
Fenhexamid CAS No: 126833-17-8 CIPAC No: 603 |
N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexane-1-carboxamide |
≥ 975 g/kg The following relevant impurity must not exceed a certain threshold in the technical material:
|
1 January 2016 |
31 December 2030 |
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on fenhexamid, and in particular Appendices I and II thereof, shall be taken into account. In this overall assessment Member States shall pay particular attention to:
Conditions of use shall include risk mitigation measures, where appropriate.’ |